Alberto D. D. S.
- Country
- Spain
- Department
- Internal medicine service
Research Overview
- Evaluation of the Impact of a Broadly Neutralizing Antibody and Attachment Inhibitor on Viral Reservoirs in HIV Patients on Integrase Inhibitor-Based Antiretroviral Therapy
- Phase 3 Randomized Non‑Inferior Trial of Ultra‑Long‑Acting Cabotegravir + Rilpivirine vs Long‑Acting Formulations in Adults/Adolescents with Virologically Suppressed HIV
- Evaluation of the Antiviral Efficacy and Safety of GSK3739937 in Treatment-Naïve Adults with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 20 of 56 partner sites.
Specializations
Oncology
Clinical research in non-small cell lung cancer, small cell lung cancer, breast cancer, hepatocellular carcinoma, colorectal cancer, prostate cancer, renal cell carcinoma, urothelial carcinoma, and lymphoma, with additional involvement in melanoma, ovarian cancer, and other advanced solid tumors.
- Thoracic malignancies
- Breast and gynecologic cancers
- Hematologic malignancies
- Genitourinary and gastrointestinal cancers
His oncology portfolio includes work in targeted therapy, immuno-oncology, and treatment strategies for advanced and recurrent malignancies.
Cardiology and Vascular Medicine
Research activity covers heart failure, atrial fibrillation, coronary artery disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, transthyretin amyloid cardiomyopathy, aortic stenosis, pulmonary hypertension, and atherosclerotic cardiovascular disease.
- Heart failure syndromes
- Cardiomyopathies
- Arrhythmia-related stroke prevention
- Pulmonary vascular disease
The therapeutic focus extends to cardiorenal and amyloid-related cardiovascular disease, alongside prevention of ischemic events.
Gastroenterology and Hepatology
His clinical trials include inflammatory bowel disease such as Crohn’s disease and ulcerative colitis, as well as non-alcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis, cirrhosis, portal hypertension, hepatocellular carcinoma, and hepatic encephalopathy.
- Inflammatory bowel disease
- Chronic liver disease
- Portal hypertension
- Liver fibrosis and cirrhosis
His research landscape also includes alpha-1 antitrypsin deficiency-associated liver disease, biliary disease, and other fibrotic liver disorders.
Nephrology and Renal Disease
Trial involvement spans chronic kidney disease, end-stage kidney disease, IgA nephropathy, focal segmental glomerulosclerosis, proteinuria, and kidney injury linked to cardiac surgery and systemic illness.
- Glomerular disease
- Chronic kidney disease
- Acute kidney injury prevention
- Cardiorenal syndromes
His therapeutic interests include renal protection, fibrosis reduction, and management of kidney involvement in metabolic and cardiovascular disease.
Autoimmune, Respiratory, and Ophthalmic Disorders
Additional research spans systemic lupus erythematosus, atopic dermatitis, psoriasis-related and other immune-mediated diseases, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, allergic rhinoconjunctivitis, macular degeneration, diabetic macular edema, and dry eye disease.
- Autoimmune skin disease
- Chronic airway disease
- Retinal and macular disease
- Inflammatory and fibrotic disorders
He is also involved in studies addressing neurologic and infectious complications, including multiple sclerosis, Parkinson’s disease, transplant-related infections, and clostridioides difficile infection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.